Genetic Polymorphisms of the HumanMDR1Drug Transporter
- 1 April 2003
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 43 (1), 285-307
- https://doi.org/10.1146/annurev.pharmtox.43.100901.140233
Abstract
P-glycoprotein is an ATP-dependent efflux pump that contributes to the protection of the body from environmental toxins. It transports a huge variety of structurally diverse compounds. P-glycoprotein is involved in limiting absorption of xenobiotics from the gut lumen, in protection of sensitive tissues (brain, fetus, testis), and in biliary and urinary excretion of its substrates. P-glycoprotein can be inhibited or induced by xenobiotics, thereby contributing to variable drug disposition and drug interactions. Recently, several SNPs have been identified in the MDR1 gene, some of which can affect P-glycoprotein expression and function. Potential implications of MDR1 polymorphisms for drug disposition, drug effects, and disease risk are discussed.Keywords
This publication has 98 references indexed in Scilit:
- A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depressionThe Pharmacogenomics Journal, 2002
- Structure and dynamics of the iron responsive element RNA: implications for binding of the RNA by iron regulatory binding proteinsJournal of Molecular Biology, 1997
- Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicineLife Sciences, 1997
- Racial variation in dosage requirements of tacrolimusThe Lancet, 1996
- Specificity of ribonucleoprotein interaction determined by RNA folding during complex formationNature, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- The Structure of an RNA Pseudoknot that Causes Efficient Frameshifting in Mouse Mammary Tumor VirusJournal of Molecular Biology, 1995
- P‐glycoprotein‐mediated transcellular transport of MDR‐reversing agentsFEBS Letters, 1993
- P-Glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistanceBiochemical and Biophysical Research Communications, 1989
- Quinidine-Digoxin InteractionNew England Journal of Medicine, 1979